In numerous tests comparing OSDrC® to the performance of conventional tableting machines and reproducibility of the tablets, OSDrC® technology has proven itself better than existing tablet technology.OSDrC® technology and equipment are protected by patents and the overall patent estate is continuously being expanded to fully protect the technology.
Measurements of the release rate of the core API (acetaminophen) in dividable tablets produced on an OSDrC® rotary tableting machine, where the tablets have a coating thickness of 0.5 mm, 1.0 mm, or 2.0 mm, verify that the release of the API can be controlled by the thickness of the coating.
Copyright © 2007 SANWA KAGAKU KENKYUSHO CO.,LTD. All rights reserved